StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.78−0.03 (-3.70%)

Close on Nov 20, 2026Market cap $43.51MP/E –Yield –

PDS Biotechnology gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for PDS Biotechnology

PDS Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More PDS Biotechnology figures

See a number that looks wrong?